Cimzia certolizumab pegol: Phase IV data

Top-line data from the single-blind, international Phase IV EXXELERATE trial in 915 RA patients showed that Cimzia plus methotrexate missed the co-primary endpoints of superiority to Humira

Read the full 277 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE